Form 4 for LH Labcorp
Accepted 2024-02-22 00:00:00 ET · period of report 2024-02-21 · accession 0001127602-24-006252 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-22 | 2024-02-21 | LH | DiVincenzo Jonathan P. | EVP, Pres, Central Labs, Intl | S - Sale | $215.49 | -500 | 3,401 | -13% | -$107.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-21 | S | D | 500 | $215.49 | 3,400.55 | D | — | — | (F1) The price of $215.4901 per share represents a weighted average of sales prices ranging from $215.46 to $215.55 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a securityholder of the issuer, full information regarding the number of shares purchased or sold at each separate price. |